University wins patent settlement

In a major settlement involving one of the first biotechnology patents ever applied for, Monsanto Co. has agreed to pay the University of California an upfront royalty of $100 million plus ongoing royalties that could easily double that amount, to resolve claims that the agribusiness giant infringed on the University's DNA patent used to make a dairy cow growth hormone. The settlement was reached a day before trial.

The patent, originally sought in 1979, covers a form of recombinant DNA to produce bovine growth hormone protein now sold under the Monsanto brand name POSILAC bovine somatotropin. The hormone increases dairy cow milk production between 10-30 percent. About 30 percent of dairy cows in America are given somatotropin and it is expected to become an increasing factor in dairy farming in developing countries.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish